Laurence A. Cole
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Laurence A. Cole has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Sarah A. Khanlian
The USA hCG Reference Service, Department of Obstetrics and Gynecology, University of New Mexico, Albuquerque, NM
8 shared publicationsCarolyn Y. Muller
6 shared publicationsAlmareena Giddings
3 shared publicationsJaime M. Sutton
USA hCG Reference Service, Department of Obstetrics and Gynecology, University of New Mexico, Albuquerque, NM 87131
3 shared publicationsSarah A Khanlian
Department of Obstetrics and Gynecology, USA hCG Reference Service, University of New Mexico, Albuquerque, NM 87131, USA
3 shared publicationsStephen A. Butler
3 shared publications
Latest Publications
- Open Access
- 1 January 2018
- Published by Allied Academies
- Vol. 02 (01)
hCG attenuates hyperglycosylated hCG-driven growth and invasion.
Objective: To determine the role of the hormone hCG in pregnancy, choriocarcinoma and cancer cell growth and invasion. Methods: Third trimester placenta cytotrophoblast primary cultures, two choriocarcinoma cell lines, and one trophoblastic cancer and 5 non-trophoblastic cancer cell lines. Results: Hyperglycosylated hCG promotes growth and invasion of normal pregnancy, 2 of 2 choriocarcinoma cell lines and 6 of 6 cancer cell lines. The hormone hCG attenuates or blocks growth and invasion in normal pregnancy, 2 of 2 choriocarcinoma and 6 of 6 cancer cell lines. Discussion: Cancer cells seemingly have adopted the hCG/LH receptor system. All cancers may be treated with hormone hCG to block and attenuate cancer growth, invasion and progression.
- 1 January 2018
- Published by Allied Academies
- Vol. 02 (01)
Open AccesshCG attenuates hyperglycosylated hCG-driven growth and invasion.
Objective: To determine the role of the hormone hCG in pregnancy, choriocarcinoma and cancer cell growth and invasion. Methods: Third trimester placenta cytotrophoblast primary cultures, two choriocarcinoma cell lines, and one trophoblastic cancer and 5 non-trophoblastic cancer cell lines. Results: Hyperglycosylated hCG promotes growth and invasion of normal pregnancy, 2 of 2 choriocarcinoma cell lines and 6 of 6 cancer cell lines. The hormone hCG attenuates or blocks growth and invasion in normal pregnancy, 2 of 2 choriocarcinoma and 6 of 6 cancer cell lines. Discussion: Cancer cells seemingly have adopted the hCG/LH receptor system. All cancers may be treated with hormone hCG to block and attenuate cancer growth, invasion and progression.
- Open Access
- 5 June 2014
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 15 (6) , 10067-10082
Direct Analysis of hCGβcf Glycosylation in Normal and Aberrant Pregnancy by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry
The analysis of human chorionic gonadotropin (hCG) in clinical chemistry laboratories by specific immunoassay is well established. However, changes in glycosylation are not as easily assayed and yet alterations in hCG glycosylation is associated with abnormal pregnancy. hCGβ-core fragment (hCGβcf) was isolated from the urine of women, pregnant with normal, molar and hyperemesis gravidarum pregnancies. Each sample was subjected to matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI TOF MS) analysis following dithiothreitol (DTT) reduction and fingerprint spectra of peptide hCGβ 6–40 were analyzed. Samples were variably glycosylated, where most structures were small, core and largely mono-antennary. Larger single bi-antennary and mixtures of larger mono-antennary and bi-antennary moieties were also observed in some samples. Larger glycoforms were more abundant in the abnormal pregnancies and tri-antennary carbohydrate moieties were only observed in the samples from molar and hyperemesis gravidarum pregnancies. Given that such spectral profiling differences may be characteristic, development of small sample preparation for mass spectral analysis of hCG may lead to a simpler and faster approach to glycostructural analysis and potentially a novel clinical diagnostic test.
- 5 June 2014
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 15 (6) , 10067-10082
Open AccessDirect Analysis of hCGβcf Glycosylation in Normal and Aberrant Pregnancy by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry
The analysis of human chorionic gonadotropin (hCG) in clinical chemistry laboratories by specific immunoassay is well established. However, changes in glycosylation are not as easily assayed and yet alterations in hCG glycosylation is associated with abnormal pregnancy. hCGβ-core fragment (hCGβcf) was isolated from the urine of women, pregnant with normal, molar and hyperemesis gravidarum pregnancies. Each sample was subjected to matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI TOF MS) analysis following dithiothreitol (DTT) reduction and fingerprint spectra of peptide hCGβ 6–40 were analyzed. Samples were variably glycosylated, where most structures were small, core and largely mono-antennary. Larger single bi-antennary and mixtures of larger mono-antennary and bi-antennary moieties were also observed in some samples. Larger glycoforms were more abundant in the abnormal pregnancies and tri-antennary carbohydrate moieties were only observed in the samples from molar and hyperemesis gravidarum pregnancies. Given that such spectral profiling differences may be characteristic, development of small sample preparation for mass spectral analysis of hCG may lead to a simpler and faster approach to glycostructural analysis and potentially a novel clinical diagnostic test.
- 28 November 2013
- Published by Springer Nature in Current Obstetrics and Gynecology Reports
- Vol. 3 (1) , 91-101
The hCG Group: the Key Molecules in Human Evolution, Human Life, and Human Death
- 28 November 2013
- Published by Springer Nature in Current Obstetrics and Gynecology Reports
- Vol. 3 (1) , 91-101
The hCG Group: the Key Molecules in Human Evolution, Human Life, and Human Death
- 1 March 2012
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 93 (2) , 119-122
Hyperglycosylated hCG and pregnancy failures
- 1 March 2012
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 93 (2) , 119-122
Hyperglycosylated hCG and pregnancy failures
- 1 February 2012
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 349 (2) , 232-238
Hyperglycosylated hCG, hCGβ and Hyperglycosylated hCGβ: Interchangeable cancer promoters
- 1 February 2012
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 349 (2) , 232-238
Hyperglycosylated hCG, hCGβ and Hyperglycosylated hCGβ: Interchangeable cancer promoters
- Open Access
- 1 January 2012
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 10 (1) , 24
hCG, the wonder of today's science
HCG is a wonder. Firstly, because hCG is such an extreme molecule. hCG is the most acidic glycoprotein containing the highest proportion of sugars. Secondly, hCG exists in 5 common forms. Finally, it has so many functions ranging from control of human pregnancy to human cancer. This review examines these molecules in detail.
- 1 January 2012
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 10 (1) , 24
Open AccesshCG, the wonder of today's science
HCG is a wonder. Firstly, because hCG is such an extreme molecule. hCG is the most acidic glycoprotein containing the highest proportion of sugars. Secondly, hCG exists in 5 common forms. Finally, it has so many functions ranging from control of human pregnancy to human cancer. This review examines these molecules in detail.
- 1 January 2012
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 50 (4) , 617-30
The hCG assay or pregnancy test
This review examines human chorionic gonadotropin (hCG) or pregnancy tests from multiple perspectives. It first investigates the molecule hCG and shows that the term represents five independent molecules differing in carbohydrate and meric structure that share a common amino acid sequence. The review goes on to show that multiple degradation produces also the need to be tested for an hCG or pregnancy test to be optimally efficient. The review then carefully examines the literature showing the sensitivity and specificity of automated laboratory tests. Point-of-care pregnancy tests are then investigated along with over-the-counter pregnancy tests. Appropriate detection of hyperglycosylated hCG, nicked hCG, nicked hCG missing the β-subunit C-terminal peptide and nicked hyperglycosylated hCG is a limitation on all pregnancy tests. In the opinion of the author, just one automated laboratory test, the Siemen’s Immulite, one point-of-care test, the Beckman-Coulter Icon 25, and one brand of over-the-counter device, First Response, are suitable for early pregnancy detection and possibly other applications.
- 1 January 2012
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 50 (4) , 617-30
The hCG assay or pregnancy test
This review examines human chorionic gonadotropin (hCG) or pregnancy tests from multiple perspectives. It first investigates the molecule hCG and shows that the term represents five independent molecules differing in carbohydrate and meric structure that share a common amino acid sequence. The review goes on to show that multiple degradation produces also the need to be tested for an hCG or pregnancy test to be optimally efficient. The review then carefully examines the literature showing the sensitivity and specificity of automated laboratory tests. Point-of-care pregnancy tests are then investigated along with over-the-counter pregnancy tests. Appropriate detection of hyperglycosylated hCG, nicked hCG, nicked hCG missing the β-subunit C-terminal peptide and nicked hyperglycosylated hCG is a limitation on all pregnancy tests. In the opinion of the author, just one automated laboratory test, the Siemen’s Immulite, one point-of-care test, the Beckman-Coulter Icon 25, and one brand of over-the-counter device, First Response, are suitable for early pregnancy detection and possibly other applications.
- 1 January 2012
- Published by Elsevier in Clinica Chimica Acta
- Vol. 413 (1-2) , 48-65
hCG, five independent molecules
- 1 January 2012
- Published by Elsevier in Clinica Chimica Acta
- Vol. 413 (1-2) , 48-65
hCG, five independent molecules
- 1 January 2012
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 93 (1) , 52-57
Familial hCG Syndrome
- 1 January 2012
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 93 (1) , 52-57
Familial hCG Syndrome